control banding


Hydroxyzine Occupational Exposure Limit (OEL) Now Immediately Available Affygility Solutions is pleased to announce the immediate availability of the OEL Fastrac monograph for hydroxyzine. Hydroxyzine, a piperazine derivative, is a sedating antihistamine with antimuscarinic and significant sedative properties; it is also an antiemetic. Hydroxyzine is mainly used in the treatment of anxiety prior to medical procedures, and for rash with itching. The most common adverse effects reported with taking hydroxyzine compounds


Affygility Solutions is pleased to announce that its next Advanced Topics in Potent Compound Safety webinar series will begin on May 30th, 2013. Potent Compound Safety Training From Your Own Office Avoid the hassle and expense of time-consuming travel. Attend this 5-module series from the convenience of your own office, or register your entire team and view in your own conference room (group discounts are available). Learn potent compound safety


Potent Compound Safety Training from the convenience of your office Affygility Solutions is please to announce that its next Advanced Topics in Potent Compound Safety webinar series will begin on Tuesday, November 20th, 2012 at 9 a.m. Mountain Time. In this 5-part webinar series, the instructors will cover the following topics Describe the basic definition of a “potent compound.” Describe at least 3 examples where occupational exposure to active pharmaceutical


Dean M. Calhoun, CIH, Affygility Solutions’ President and CEO will be presenting at the High Potent Drugs 2013 conference in Mumbai, India to be held on January 23rd and 24th, 2013. Mr. Calhoun will be presenting on Potent Compound Categorization and Future Opportunities. To view details on this conference, go to the High Potent Drug 2013 conference website. In his presentation, Dean will discuss the following items: Understanding control banding


Affygility Solutions is please to annonce that its video on “Introduction to Potent Compound Safety – Protecting Employees and Product Quality” is now available for INSTANT download. In this 29-minute, highly visual video, we will discuss the following topics: The Definition of a Potent Compound; Why Employees Should Care about Preventing Occupational Exposure to Potent Compounds; Basic Occupational Health Control Banding or Categorization Principles and Concepts; Controlling Occupational Exposure to


Here at Affygility Solutions, we often get asked the question, “Does the form of the compound change its control band assignment?” In this short 2:37 minute video, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions answers that question. If you have any questions, comments, or need additional information on the risk management of potent compounds, please contact Affygility Solutions via their main website.


Here at Affygility Solutions, we are often asked the question, “Should I use 4 or 5 controls bands in my occupational exposure control banding system? In this brief video, Dean M. Calhoun, CIH, the President and CEO of Affygility Solutions answers this important question. In the image below, we present a comparison between the Affygility Solutions control banding system, the Merck system, and a typical 4-band system. When translating from


Affygility Solutions - provider of potent compound safety, webinars, and compliance management software